[144] UNITEDHEALTH GROUP INCORPORATED (Delaware) SEC Filing

Rhea-AI Filing Summary

UnitedHealth Group (UNH) filer submitted a Form 144 reporting a proposed sale of company common stock. The notice shows 27 shares intended for sale on the NYSE through J.P. Morgan Securities LLC with an aggregate market value of $9,363.06 and an approximate sale date of 09/11/2025. The securities were acquired by transfer on 08/01/2025 from the "Barbara L S Schadt Terminating Trust UAD 12-16-2015" and payment/consideration is listed as N/A. The form indicates no securities sold in the prior three months and contains standard signature and representation language. Some filer identifiers and contact details are not provided in the content.

Insights

Securities Analyst

TL;DR: Small, routine Rule 144 notice for 27 shares; immaterial to company valuation or control.

This Form 144 documents a proposed sale of a very small position—27 shares—executed through a broker and acquired by transfer from a named trust one month prior to the planned sale. The aggregate value reported is $9,363.06, which is negligible relative to UnitedHealth Group's market capitalization. There are no reported prior sales in the past three months. The filing includes the required representation about material nonpublic information. Given the size and nature of the transaction, this filing is procedural and unlikely to be material to investors.

Corporate Governance Expert

TL;DR: Administrative disclosure reflecting a trust-origin transfer and subsequent planned sale; governance risk appears minimal.

The notice shows a transfer from a named terminating trust followed by an intended brokered sale. The form includes required attestations regarding material information and trading-plan language. No leadership changes, regulatory issues, or large insider dispositions are reported. From a governance perspective, the filing signals compliance with Rule 144 procedures and does not raise substantive governance concerns based on the provided details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue - 6th Floor New York NY 10017	27	9363.06	905673625	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2025	Transfer	Barbara L S Schadt Terminating Trust UAD 12-16-2015			27	08/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the UNH Form 144 report?

The form reports a proposed sale of 27 shares of UnitedHealth Group common stock via J.P. Morgan Securities LLC with an aggregate market value of $9,363.06 and an approximate sale date of 09/11/2025.

Who transferred the shares being sold on the UNH Form 144?

The 27 shares were acquired by transfer on 08/01/2025 from the "Barbara L S Schadt Terminating Trust UAD 12-16-2015."

Were there any shares of UNH sold by the filer in the past three months?

No; the filing states "Nothing to Report" for securities sold during the past three months.

Through which broker will the UNH shares be sold?

The proposed sale is to be executed through J.P. Morgan Securities LLC located at 390 Madison Avenue, New York, NY.

Does the Form 144 indicate any material nonpublic information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.